Seasonal Impact on Grade ≥2 Dermatitis in Patients With Breast Cancer Undergoing Radiotherapy: A Supplementary Analysis
Anticancer Research · 2024
DOI: 10.21873/anticanres.17067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Dirk Rades und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de. Hauptthemen laut MEDLINE: Breast Neoplasms, Seasons, Radiodermatitis.
Abstract (Originalsprache)
BACKGROUND/AIM: We investigated grade ≥2 dermatitis in patients irradiated for breast cancer. This study evaluated associations between dermatitis and the season during which radiotherapy took place. PATIENTS AND METHODS: Associations between the season and grade ≥2 dermatitis were retrospectively evaluated in 327 breast cancer patients. Seasons were March to May (spring), June to August (summer), September to November (autumn), and December to February (winter). Subgroup analyses were performed considering fractionation, radiation technique, treatment volume, radiation boost, and deep-inspiration breath-hold technique. Furthermore, warmer and cooler months were compared. RESULTS: The season had no significant impact on the rate of grade ≥2 dermatitis in the entire cohort (p=0.63) nor in the subgroup analyses (p-values between 0.17 and 0.82). No significant difference in rate was found between warm and cool months. CONCLUSION: Grade ≥2 dermatitis was not associated with the season during which radiotherapy was performed. This factor may not be important for stratification in prospective trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de.
- Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Lübeck Campus, Lübeck, Germany.
- Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.
- Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Odense, Denmark.
- Department of Radiotherapy, Malteser Hospital St. Franziskus, Flensburg, Germany.
- Department for Human Medicine, MSH Medical School Hamburg, Hamburg, Germany.
Zitieren
APA
Rades, D., Janssen, S., Narvaez-Wolf, C. A., Kristiansen, C., Timke, C., Duma, M. N., Bartscht, T., & Yu, N. Y. (2024). Seasonal Impact on Grade ≥2 Dermatitis in Patients With Breast Cancer Undergoing Radiotherapy: A Supplementary Analysis. Anticancer Research. https://doi.org/10.21873/anticanres.17067
Vancouver
Rades D, Janssen S, Narvaez-Wolf CA, Kristiansen C, Timke C, Duma MN, et al. Seasonal Impact on Grade ≥2 Dermatitis in Patients With Breast Cancer Undergoing Radiotherapy: A Supplementary Analysis. Anticancer Research. 2024. doi:10.21873/anticanres.17067
BibTeX
@article{Rades2024,
author = {Rades, Dirk and Janssen, Stefan and Narvaez-Wolf, Carlos A and Kristiansen, Charlotte and Timke, Carmen and Duma, Marciana N and Bartscht, Tobias and Yu, Nathan Y},
title = {Seasonal Impact on Grade ≥2 Dermatitis in Patients With Breast Cancer Undergoing Radiotherapy: A Supplementary Analysis},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17067}
}
EUVIMED